These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7378262)

  • 21. Effects of thioridazine on serum testosterone.
    Laughren TP; Brown WA; Petrucci JA
    Am J Psychiatry; 1978 Aug; 135(8):982-4. PubMed ID: 665850
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic interactions between nortriptyline and thioridazine in rats.
    Fuller RW; Snoddy HD; Slater IH
    Toxicol Appl Pharmacol; 1974 Aug; 29(2):259-69. PubMed ID: 4283691
    [No Abstract]   [Full Text] [Related]  

  • 23. A STUDY OF THE BEHAVIOR AND EEG PATTERNS OF PATIENTS RECEIVING TRANQUILIZERS WITH AND WITHOUT THE ADDITION OF CHLORDIAZEPOXIDE.
    ULETT GA; BOWERS CA; HEUSLER AF; QUICK R; WORD T; WORD V
    J Neuropsychiatr; 1964 Dec; 5():558-65. PubMed ID: 14252302
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of antipsychotic drugs on body weight: a retrospective review.
    Doss FW
    J Clin Psychiatry; 1979 Dec; 40(12):528-30. PubMed ID: 40965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
    Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
    Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COMPARISON OF THREE PHENOTHIAZINES ON CHRONIC PSYCHOTIC BEHAVIOR.
    HINDLEY JP; KERIN MT; THOMPSON M
    Dis Nerv Syst; 1965 Feb; 26():91-8. PubMed ID: 14256067
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of oral fluphenazine on Huntington's chorea.
    Whittier JR; Korenyi C
    Int J Neuropsychiatry; 1968 Feb; 4(1):1-3. PubMed ID: 4230793
    [No Abstract]   [Full Text] [Related]  

  • 28. [The influence of thioridazine on the catalase activity in the serum of oligophrenics and in gerontopsychiatric patients].
    Zapletálek M; Komenda S
    Psychiatr Neurol Med Psychol (Leipz); 1965 Feb; 17(2):71-3. PubMed ID: 5832916
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluphenazine decanoate: plasma concentrations and clinical response [proceedings].
    Nasrallah HA; Rivera-Calimlin L; Rogol AD
    Psychopharmacol Bull; 1978 Jul; 14(3):46-7. PubMed ID: 353871
    [No Abstract]   [Full Text] [Related]  

  • 30. Change in human electroretinography associated with thioridazine administration.
    Miyata M; Imai H; Ishikawa S; Nakajima S
    Ophthalmologica; 1980; 181(3-4):175-80. PubMed ID: 7231884
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrocardiographic changes and serum concentrations in thioridazine-treated patients.
    Axelsson R; Aspenstrom G
    J Clin Psychiatry; 1982 Aug; 43(8):332-5. PubMed ID: 7096274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA; Silver MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
    Jayaram G; Coyle J; Tune L
    J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a D1 dopamine receptor in the salivary glands of Amblyomma americanum (L.).
    Schmidt SP; Essenberg RC; Sauer JR
    J Cyclic Nucleotide Res; 1981; 7(6):375-84. PubMed ID: 7346526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PHENOTHIAZINES IN THE TREATMENT OF NEWLY ADMITTED STATE HOSPITAL PATIENTS: GLOBAL COMPARISON OF EIGHT COMPOUNDS IN TERMS OF AN OUTCOME INDEX.
    MICHAUX MH; HANLON TE; OTA KY; KURLAND AA
    Curr Ther Res Clin Exp; 1964 May; 6():331-9. PubMed ID: 14193762
    [No Abstract]   [Full Text] [Related]  

  • 36. [THE SECONDARY EFFECTS OF NEUROLEPTICS].
    DELAY J; DENIKER P
    Encephale; 1964; 53():SUPPL:103-8. PubMed ID: 14161522
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute effects of alcohol, diazepam, thioridazine, flupenthixole and atropine on psychomotor performance profiles.
    Linnoila M; Mäki M
    Arzneimittelforschung; 1974 Apr; 24(4):565-9. PubMed ID: 4408151
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics].
    Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of thioridazine on cognitive, psychomotor, and reaction performance in patients with dysthymic-depressive syndrome (author's transl)].
    Meyer FP; Walther H; Kühne GE
    Pharmacopsychiatria; 1981 May; 14(3):94-9. PubMed ID: 7255542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of fluphenazine in plasma after decanoate withdrawal.
    Gitlin MJ; Midha KK; Fogelson D; Nuechterlein K
    J Clin Psychopharmacol; 1988 Feb; 8(1):53-6. PubMed ID: 3351000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.